First report of high levels of clindamycin-resistant Propionibacterium acnes carrying erm(X) in Japanese patients with acne vulgaris

Journal of Dermatology

Volumn 39, Issue 9, 2012, Pages 794-796

  Nakase, Keisuke ^a   Nakaminami, Hidemasa ^a   Noguchi, Norihisa ^a   Nishijima, Setsuko ^b   Sasatsu, Masanori ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^b Nishijima Skin Clinic   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CEFACLOR; CEFDITOREN; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; FROPENEM; JOSAMYCIN; LEVOFLOXACIN; MINOCYCLINE; NADIFLOXACIN; RNA 23S;

ACNE VULGARIS; ANTIBIOTIC RESISTANCE; BACTERIAL GENETICS; CONCENTRATION RESPONSE; DNA SEQUENCE; GENE; GENE MUTATION; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; JAPANESE; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROPIONIBACTERIUM ACNES;

ACNE VULGARIS; ANTI-BACTERIAL AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; CLINDAMYCIN; DRUG RESISTANCE, BACTERIAL; FEMALE; GENES, BACTERIAL; HUMANS; JAPAN; MALE; PROPIONIBACTERIUM ACNES; YOUNG ADULT;

EID: 84865642111     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2011.01423.x     Document Type: Letter

References (10)

1. Iinuma K, Sato T, Akimoto N, et al. Involvement of Propionibacterium acnes in the augmentation of lipogenesis in hamster sebaceous glands in vivo and in vitro. J Invest Dermatol 2009; 129: 2113-2119.
2. Hayashi N, Akamatsu H, Iwatsuki K, et al. A acne vulgaris treatment guideline. Jpn J Dermatol 2008; 118: 1893-1923.
3. Ishida N, Nakaminami H, Noguchi N, Kurokawa I, Nishijima S, Sasatsu M,. Antimicrobial susceptibilities of Propionibacterium acnes isolated from patients with acne vulgaris. Microbiol Immunol 2008; 52: 621-624.
4. Ross JI, Snelling AM, Carnegie E, et al. Antibiotic-resistant acne: lessons from Europe. Br J Dermatol 2003; 148: 467-478.
5. Weisblum B,. Erythromycin resistance by ribosome modification. Antimicrob Agents Chemother 1995; 39: 577-585.
6. Song M, Seo SH, Ko HC, et al. Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea. J Dermatol 2011; 38: 667-673.
7. Japan Society of Chemotherapy. Method for the determination of minimum inhibitory concentration (MIC) of anaerobic bacteria by agar dilution method. Chemotherapy 1979; 27: 559-560.
8. Nakaminami H, Noguchi N, Sasatsu M,. Fluoroquinolone efflux by the plasmid-mediated multidrug efflux pump QacB variant QacBIII in Staphylococcus aureus. Antimicrob Agents Chemother 2010; 54: 4107-4111.
9. El-Mahdy TS, Abdalla S, El-Domany R, Mohamed MS, Ross JI, Snelling AM,. Detection of a new erm(X)-mediated antibiotic resistance in Egyptian cutaneous propionibacteria. Anaerobe 2010; 16: 376-379.
10. Thiboutot D, Gollnick H, Bettoli V, et al. New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group. J Am Acad Dermatol 2009; 60: S1-S50.